Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Patient Treatment Outside of Clinical Trial
http://www.globenewswire.com/news-release/2020/08/27/2084660/0/en/Pluristem-Launches-FDA-Cleared-COVID-19-Expanded-Access-Program-Enabling-Patient-Treatment-Outside-of-Clinical-Trial.html
Cell Therapy News/Articles, page-6015
-
- There are more pages in this discussion • 11,810 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $16.39M | 13.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 45499 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 257491 | 18 |
View Market Depth
| Last trade - 14.05pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |